We are rapidly moving towards individualized treatments and disease interventions that will change how we care for people around the world.
For years, patients diagnosed with a disease often received the same treatment. And for some people, that treatment worked. However, for others, it did not at all work – or only marginally or with serious side effects. This meant that, on average, only 50% of patients benefited from their treatment. With the mapping of the genome in combination with new, analytical scientific and technological advances, we can now develop personalized treatments for individuals or patient populations.
Huge advances in areas like cell and gene therapy, specifically in oncology and rare diseases are changing the treatment landscape. We conducted research to understand the key trends in precision oncology and how leaders are responding.
It’s our privilege to be working with the most progressive life sciences companies to bring precision medicine to people around the world.